Loading clinical trials...
Loading clinical trials...
Psychological well-being and cognitive function will be measured in patients enrolled on the primary study, NCT01790568, a phase 2 trial of vorinostat plus tacrolimus and methotrexate to prevent graft...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Sung Choi, M.D.
NCT05883540 · Palliative Care, Pain, and more
NCT07546435 · Psychological Experience in Fertility Treatment, Hypogonadism, and more
NCT06395558 · Cognitive Impairment, Depression, Anxiety, and more
NCT07123298 · Social Isolation in Older Adults, Social Isolation or Loneliness, and more
NCT06326905 · Quality of Life, Depression, and more
University of Michigan Health System
Ann Arbor, Michigan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions